DiaMedica Therapeutics Inc.
DMAC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $168 | $162 | $233 |
| - Cash | $3 | $4 | $3 | $3 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $164 | $160 | $230 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$9 | -$8 | -$8 | -$8 |
| % Margin | – | – | – | – |
| Net Income | -$9 | -$8 | -$8 | -$8 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.17 | -0.18 | -0.18 | -0.18 |
| % Growth | 5.6% | 0% | 0% | – |
| Operating Cash Flow | -$7 | -$8 | -$7 | -$6 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$7 | -$8 | -$7 | -$6 |